Jeffrey L. Ives

Insider Reports History

Location
Shelton, CT
Signature
/s/ Derek Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey L. Ives:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cara Therapeutics, Inc. Director Common Stock 198,485 $148,864 $0.7500 04 Jun 2024 Direct
Acumen Pharmaceuticals, Inc. Director Common Stock 12,800 $14,080 $1.10 04 Jun 2025 Direct
Cara Therapeutics, Inc. Director Stock Option (Right to Buy) 195,000 04 Jun 2024 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 19,500 04 Jun 2025 Direct

Insider Reports Filed by Jeffrey L. Ives

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABOS Acumen Pharmaceuticals, Inc. 04 Jun 2025 2 $0 4 Director 05 Jun 2025, 16:52
ABOS Acumen Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:54
TVRD Cara Therapeutics, Inc. 04 Jun 2024 2 $0 4 Director 06 Jun 2024, 16:25
ABOS Acumen Pharmaceuticals, Inc. 17 Aug 2023 6 -$240,814 4 Director 18 Aug 2023, 19:31
ABOS Acumen Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:43
TVRD Cara Therapeutics, Inc. 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 16:33
TVRD Cara Therapeutics, Inc. 15 Jul 2022 1 -$32,580 4 Director 19 Jul 2022, 17:16
ABOS Acumen Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:25
TVRD Cara Therapeutics, Inc. 02 Jun 2022 2 $0 4 Director 06 Jun 2022, 17:51
TVRD Cara Therapeutics, Inc. 12 Nov 2021 1 -$131,207 4 Director 16 Nov 2021, 17:15
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:18
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 Director 30 Jun 2021, 18:57
TVRD Cara Therapeutics, Inc. 03 Jun 2021 3 -$32,886 4 Director 07 Jun 2021, 19:25